200 related articles for article (PubMed ID: 9402493)
21. The characteristics of mediastinal neuroblastoma.
Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Tasaka H; Yano H; Akiyama H; Ikeda K
Eur J Pediatr Surg; 2000 Dec; 10(6):353-9. PubMed ID: 11215774
[TBL] [Abstract][Full Text] [Related]
22. Detection of N-myc amplification by FISH in immature areas of fixed neuroblastomas: more efficient than Southern blot/PCR.
Sartelet H; Grossi L; Pasquier D; Combaret V; Bouvier R; Ranchère D; Plantaz D; Munzer M; Philip T; Birembaut P; Zahm JM; Bergeron C; Gaillard D; Pasquier B
J Pathol; 2002 Sep; 198(1):83-91. PubMed ID: 12210067
[TBL] [Abstract][Full Text] [Related]
23. Adrenal neuroblastoma in an adult: report of a case.
Genc FA; Aksoy M; Kapran Y; Tunca F; Tanakol R; Basar Y; Terzioglu T
Surg Today; 2003; 33(11):879-81. PubMed ID: 14605964
[TBL] [Abstract][Full Text] [Related]
24. [Neuroblastoma IV-S. A series of 7 cases].
Maciá Martí J; Sánchez de Toledo J; Prats Viñas J; Pérez Payarols J; Gallego Melcón S; Herránz Alvarez M; Urbán Ramón A
An Esp Pediatr; 1985 Feb; 22(2):137-42. PubMed ID: 3985505
[TBL] [Abstract][Full Text] [Related]
25. Molecular alterations in a case of bilateral adrenal neuroblastoma.
Lo Cunsolo C; Casciano I; Gambini C; De Bernardi B; Tonini GP; Romani M
Med Pediatr Oncol; 2001 Apr; 36(4):491-3. PubMed ID: 11260574
[No Abstract] [Full Text] [Related]
26. Bilateral adrenal neuroblastoma.
Shaw A; Sabio H
Am J Pediatr Hematol Oncol; 1984; 6(1):41-3. PubMed ID: 6711761
[TBL] [Abstract][Full Text] [Related]
27. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
Martinsson T; Sjöberg RM; Hedborg F; Kogner P
Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
[TBL] [Abstract][Full Text] [Related]
28. Significance of chromosome 1p loss of heterozygosity in neuroblastoma.
Maris JM; White PS; Beltinger CP; Sulman EP; Castleberry RP; Shuster JJ; Look AT; Brodeur GM
Cancer Res; 1995 Oct; 55(20):4664-9. PubMed ID: 7553646
[TBL] [Abstract][Full Text] [Related]
29. Biological aspects of neuroblastomas identified by mass screening in Quebec.
Brodeur GM; Look AT; Shimada H; Hamilton VM; Maris JM; Hann HW; Leclerc JM; Bernstein M; Brisson LC; Brossard J; Lemieux B; Tuchman M; Woods WG
Med Pediatr Oncol; 2001 Jan; 36(1):157-9. PubMed ID: 11464873
[TBL] [Abstract][Full Text] [Related]
30. Expression of N-myc and c-src protooncogenes correlating to the undifferentiated phenotype and prognosis of primary neuroblastomas.
Matsunaga T; Takahashi H; Ohnuma N; Tanabe M; Yoshida H; Iwai J; Shirasawa H; Simizu B
Cancer Res; 1991 Jun; 51(12):3148-52. PubMed ID: 2039993
[TBL] [Abstract][Full Text] [Related]
31. Establishment of a novel neuroblastoma mouse model.
Iwakura H; Ariyasu H; Kanamoto N; Hosoda K; Nakao K; Kangawa K; Akamizu T
Int J Oncol; 2008 Dec; 33(6):1195-9. PubMed ID: 19020752
[TBL] [Abstract][Full Text] [Related]
32. A neuroblastoma cell line derived from a case detected through a mass screening system in Japan: a case report including the biologic and phenotypic characteristics of the cell line.
Hiraiwa H; Hamazaki M; Takata A; Kikuchi H; Hata J
Cancer; 1997 May; 79(10):2036-44. PubMed ID: 9149033
[TBL] [Abstract][Full Text] [Related]
33. Surgical aspects of N-myc oncogene amplification of neuroblastoma.
Nakagawara A; Ikeda K; Yokoyama T; Tsuda T; Higashi K
Surgery; 1988 Jul; 104(1):34-40. PubMed ID: 3388178
[TBL] [Abstract][Full Text] [Related]
34. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group.
George RE; Kenyon RM; McGuckin AG; Malcolm AJ; Pearson AD; Lunec J
Oncogene; 1996 Apr; 12(7):1583-7. PubMed ID: 8622876
[TBL] [Abstract][Full Text] [Related]
35. [Familial neuroblastoma].
Nakamura M; Ohi R; Hayashi Y
Nihon Rinsho; 1995 Nov; 53(11):2684-7. PubMed ID: 8538026
[TBL] [Abstract][Full Text] [Related]
36. Poor outcome in patients with advanced stage neuroblastoma and coincident opsomyoclonus syndrome.
Hiyama E; Yokoyama T; Ichikawa T; Hiyama K; Kobayashi M; Tanaka Y; Ueda K; Tanaka Y; Yano H
Cancer; 1994 Sep; 74(6):1821-6. PubMed ID: 8082085
[TBL] [Abstract][Full Text] [Related]
37. Stage IVS neuroblastoma: a clinical, histological, and biological analysis of 45 cases.
Hachitanda Y; Hata J
Hum Pathol; 1996 Nov; 27(11):1135-8. PubMed ID: 8912820
[TBL] [Abstract][Full Text] [Related]
38. [The "definitely" prenatally developed neuroblastoma. A review].
Bachmann KD
Geburtshilfe Frauenheilkd; 1983 Jun; 43 Suppl 1():111-4. PubMed ID: 6555124
[TBL] [Abstract][Full Text] [Related]
39. [Molecular genetic abnormalities of N-myc and C-myc in pediatric neuroblastic tumors and clinical pathologic significance].
Cai RQ; Zhou CJ; Sun QN; Ma XL; Wang M; Li Y; Wang DY; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):299-304. PubMed ID: 24004585
[TBL] [Abstract][Full Text] [Related]
40. Neuroblastoma in monozygotic twins with distinct presentation pathology and outcome: is it familial or in utero metastasis.
Abu-Arja R; Hashem H; El-Sheikh A; Abusin G
Pediatr Blood Cancer; 2014 Jun; 61(6):1124-5. PubMed ID: 24376049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
